ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/024/SRR25895324/SRR25895324_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/026/SRR25895326/SRR25895326_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/020/SRR25895320/SRR25895320_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/027/SRR25895327/SRR25895327_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/028/SRR25895328/SRR25895328_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/022/SRR25895322/SRR25895322_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/023/SRR25895323/SRR25895323_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/026/SRR25895326/SRR25895326_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/020/SRR25895320/SRR25895320_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/023/SRR25895323/SRR25895323_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/021/SRR25895321/SRR25895321_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/027/SRR25895327/SRR25895327_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/024/SRR25895324/SRR25895324_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/021/SRR25895321/SRR25895321_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/025/SRR25895325/SRR25895325_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/022/SRR25895322/SRR25895322_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/025/SRR25895325/SRR25895325_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR258/028/SRR25895328/SRR25895328_1.fastq.gzprimaryOK200GenomicsZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Scienceshttps://www.ebi.ac.uk/ena/browser/view/PRJNA1012565MGC803 cells were treated with different concentrations of compound XX_3(0 or 2 Micromolar) and XYA_2 (0 or 2 Micromolar) for 24 h with three repeats for each condition.ENAfalseRNA-seq of MGC803 cells with XX_3 and XYA_2 treatment2023-09-052023-09-05PRJNA1012565